Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

| More on:
A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

News Corp (ASX: NWS)

According to a note out of Goldman Sachs, its analysts have retained their conviction buy rating and increased their price target on this media giant's shares to $44.50. This follows the release of its full year result last week. And while News Corp fell a touch short of its expectations, the broker remains very positive on its outlook. It is forecasting operating earnings growth of 17% in FY 2022. It also believes share buybacks could unlock value for shareholders. The News Corp share price is trading at $32.37 today.

REA Group Limited (ASX: REA)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $185.00 price target on this property listings company's shares. Morgan Stanley was pleased with REA's FY 2021 result. And while it suspects that its first half result could be a touch softer than expected in FY 2022 because of lockdowns, it expects listing volumes to rebound quickly. In light of this, it appears to believe any short term share price weakness would be a buying opportunity. The REA share price is fetching $154.24 today.

ResMed Inc (ASX: RMD)

Analysts at Morgans have retained their add rating and lifted their price target on this sleep treatment company's shares by almost 42% to $41.34. This follows the release of a stronger than expected fourth quarter update last week. It also notes that management expects a US$300 million to US$350 million revenue benefit in FY 2022 from the product recall by rival Philips. The broker notes that this has led to unsatisfied demand everywhere. Though, Morgans acknowledges that bottlenecks in the supply chain could limit the benefit from pent-up demand for devices. The ResMed share price is trading at $37.77 today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 stocks could rise 20% to 35%

Analysts think these shares could be heading significantly higher.

Read more »

man with dog on his lap looking at his phone in his home.
Broker Notes

Buy, hold, sell: CBA, CSL, and DroneShield shares

Lets see if analysts are bullish or bearish on these popular shares.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

3 ASX All Ords shares tipped to rise 30% to 80% in 2026

Looking for New Year's investment inspiration?

Read more »

Man in yellow hard hat looks through binoculars as man in white hard hat stands behind him and points.
Broker Notes

4 ASX shares to buy in the market's best-performing sector of 2025

Do these companies deserve a spot in your portfolio?

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: AGL, Coles, and PLS shares

Are analysts bullish or bearish on these shares?

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Man reading an e-book with his feet up and piles of books next to him.
Broker Notes

What's Bell Potter's view on SGH shares after the BlueScope Steel acquisition proposal?

What should investors expect after Monday's announcement?

Read more »